Atlas Trials

Pediatric Pyruvate Kinase Deficiency

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Pediatric Pyruvate Kinase Deficiency

RecordFirmDate
A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension Period (NCT05144256)Agios Pharmaceuticals, Inc.2022-06-08
A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Not Regularly Transfused, Followed by a 5-Year Extension Period (NCT05175105)Agios Pharmaceuticals, Inc.2022-06-06

Track Pediatric Pyruvate Kinase Deficiency automatically

Every clearance here is in the API, with alerts when new ones post.